title: A Ghostly OCT.
authors.affiliation: Dalhousie University, Halifax, N.S.. Electronic address: mark.e.seamone@dal.ca.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Seamone
authors.affiliation: Herzing Eye Institute, Toronto, Ont.
authors.forename: Netan
authors.initials: N
authors.lastname: Choudhry
authors.affiliation: Dalhousie University, Halifax, N.S.
authors.forename: Rishi
authors.initials: R
authors.lastname: Gupta
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D016477:Artifacts; D003930:Diabetic Retinopathy / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D008269:Macular Edema / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A